Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 4/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | NOS1 | P29475 | 3/20 | 0.35 |
| ▸ | NOS2 | P35228 | 3/20 | 0.35 |
| ▸ | NOS3 | P29474 | 2/20 | 0.35 |
| ▸ | PPARG | P37231 | 2/20 | 0.33 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.33 |
| ▸ | TLR4 | O00206 | 1/20 | 0.32 |
| ▸ | HLCS | P50747 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 2/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.31 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | PKM | P14618 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16582914 | 0.98 | CYP1A2 (0.45) | CYP1A2ALDH1A1L3MBTL1NOS1NOS2 | |
| SCHEMBL9680240 | 0.94 | CYP1A2 (0.40) | CYP1A2ALDH1A1L3MBTL1NOS1NOS2 | |
| SCHEMBL9680233 | 0.94 | CYP1A2 (0.40) | CYP1A2ALDH1A1L3MBTL1NOS1NOS2 | |
| SCHEMBL3383889 | 0.86 | NOS3 (0.34) | CYP1A2NOS1NOS2NOS3MAPT | |
| SCHEMBL2691445 | 0.84 | CYP1A2 (0.55) | CYP1A2ALDH1A1L3MBTL1NOS1NOS2 | |
| SCHEMBL19976638 | 0.82 | CYP1A2 (0.53) | CYP1A2ALDH1A1L3MBTL1NOS1NOS2 | |
| SCHEMBL2690939 | 0.82 | CYP1A2 (0.53) | CYP1A2ALDH1A1L3MBTL1NOS1NOS2 | |
| SCHEMBL6707183 | 0.82 | CYP1A2 (0.53) | CYP1A2ALDH1A1L3MBTL1NOS1NOS2 | |
| SCHEMBL15526526 | 0.78 | MAPT (0.32) | NOS1NOS2NOS3MEN1KMT2A | |
| SCHEMBL2691102 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9512059-B2 | Killing of bed bugs | BEDOUKIAN RESEARCH, INC. (US) | 2016-12-06 | — | — | US | disclosed |
| US-20150087855-A1 | KILLING OF BED BUGS | BEDOUKIAN RESEARCH,INC. (US) | 2015-03-26 | — | — | US | disclosed |
| EP-2844066-A1 | KILLING OF BED BUGS | Bedoukian Research, Inc. (US) | 2015-03-11 | — | — | EP | disclosed |
| WO-2013165475-A1 | KILLING OF BED BUGS | BEDOUKIAN RESEARCH, INC. (US) | 2013-11-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150087855-A1 | KILLING OF BED BUGS | L3MBTL3, L3MBTL4, CYCS | CYP1A2 194/4885ALDH1A1 2005/4885L3MBTL1 4/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.